Moreover, Gremlin1 neutralising antibodies were able to shrink tumour size and promote Lgr5+ intestinal stem‐cell differentiation, confirming that Gremlin1 can be oncogenic via promoting WNT stem cell signalling [40]. The gene discussed is LGR5; the disease is neoplasm.